Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Jonathan M Hill1, Gloria Zalos, Julian P J Halcox

  • 1Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1622, USA.

The New England Journal of Medicine
|February 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank.

Journal of the American Heart Association·2026
Same author

Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trial.

American journal of preventive cardiology·2026
Same author

Coronary sinus reducer implantation for refractory angina: a national audit of UK practice.

Heart (British Cardiac Society)·2026
Same author

Racism-Related Concern for Children and Central Hemodynamics in African American Women: A Longitudinal Study.

Biopsychosocial science and medicine·2026
Same author

Age at type 2 diabetes diagnosis, mortality, and health loss in South Asians.

Diabetes research and clinical practice·2026
Same author

Dyslipidemia and therapies after heart transplantation: Current evidence and future directions.

Journal of clinical lipidology·2026

Low levels of circulating endothelial progenitor cells (EPCs) correlate with poor vascular function and increased cardiovascular risk. Insufficient EPCs may drive disease progression, highlighting their role in endothelial repair.

Area of Science:

  • Cardiovascular biology
  • Regenerative medicine
  • Vascular health

Background:

  • Cardiovascular risk factors promote atherogenesis via endothelial cell injury.
  • Endothelial progenitor cells (EPCs) from bone marrow are hypothesized to play a role in endothelial repair.
  • Impaired EPC mobilization or depletion may contribute to endothelial dysfunction and cardiovascular disease (CVD).

Purpose of the Study:

  • To investigate the relationship between circulating endothelial progenitor cells (EPCs) and cardiovascular risk.
  • To assess the association between EPC levels and endothelial function in men with varying cardiovascular risk.
  • To determine if EPCs can serve as a biomarker for vascular health.

Main Methods:

  • Quantified colony-forming units of EPCs in peripheral blood from 45 men (mean age 50 years) with diverse cardiovascular risk.

Related Experiment Videos

  • Assessed endothelium-dependent and independent vascular function using high-resolution brachial artery ultrasonography.
  • Evaluated in vitro senescence rates of EPCs in relation to cardiovascular risk levels.

    • Main Results:

    • A significant negative correlation was found between circulating EPC numbers and Framingham risk scores (r=-0.47, P=0.001).
    • Higher EPC levels strongly correlated with improved flow-mediated brachial artery reactivity (r=0.59, P<0.001).
    • Circulating EPC levels were a superior predictor of vascular reactivity compared to conventional risk factors; high-risk subjects had more senescent EPCs.

    Conclusions:

    • Circulating EPC levels may serve as a biological marker for vascular function and cumulative cardiovascular risk in healthy men.
    • Endothelial injury coupled with insufficient circulating EPCs may influence the progression of cardiovascular disease.
    • These findings underscore the potential of EPCs as therapeutic targets for cardiovascular conditions.